查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869990

mRNA品质监测市场规模、份额和趋势分析报告：按产品/服务、技术、最终用途、地区和细分市场预测（2025-2033年）

mRNA Quality Monitoring Market Size, Share & Trends Analysis Report By Product & Service, By Technology (Electrophoresis, LC-MS, PCR Techniques), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

mRNA品质监测市场摘要

2024年全球mRNA品质监测市场规模估计为12.8亿美元，预计2033年将达到23.3亿美元。

预计2025年至2033年间，该市场将以6.93%的复合年增长率成长。 mRNA疗法和疫苗的日益普及推动了对严格品质监控的需求，以确保产品的安全性、有效性和合规性。此外，分析技术（液相层析质谱联用、电泳、qPCR）的进步以及外包给合约研发开发机构（CDMO）/合约研究机构（CRO）的增加，也进一步促进了市场成长。

mRNA疗法和疫苗的激增

随着新冠疫苗的成功，mRNA技术已广泛应用，生物製药公司正大幅拓展其在感染疾病以外的研发管线。 Moderna、BioNTech和CureVac等公司正大幅扩大生产规模和复杂性，以开发用于蛋白质替代、罕见疾病和肿瘤治疗的mRNA疗法。为了符合GMP和监管要求，更多批次的产品必须接受严格的品质监控，涵盖完整性、纯度、封盖效率、残留污染物等多个面向。

在全球范围内，大规模投资正在进行中，以支持这一趋势。为了扩大疫苗生产规模，BioNTech公司在卢安达安装了一套模组化mRNA生产装置（BioNTainers），并在德国马尔堡新建了一座质体DNA生产设施。同样，Moderna公司也在澳洲墨尔本建立了一座商业化mRNA工厂，年产能高达1亿剂。 mRNA品质监测产业的发展动力源自于对先进分析工具的需求，例如液相层析-质谱联用（LC-MS）、电泳和聚合酶炼式反应（PCR），因为每个生产设施都必须在从原材料检验到成品出货的多个阶段进行全面的品管检测。

技术创新和外包趋势

数位和分析技术的快速发展正在革新mRNA品管。新一代液相层析质谱联用（LC-MS）系统灵敏度更高、分析时间更短，使得mRNA的精细结构分析成为可能。此外，微流体毛细管电泳技术能够以极少的样品量实现高通量完整性分析。次世代定序（NGS）和数位PCR（dPCR）技术也正被结合用于精确的定量和序列检验。这些进步推动了品质控制流程的自动化、标准化和可重复性不断提高，从而促进mRNA生产从临床阶段到商业化生产的规模化。

同时，许多中小型生物技术公司正越来越多地将品质控制活动外包给合约研发生产力机构（CDMO）、合约研究机构（CRO）和专业分析实验室。外包使这些公司避免了在设备和监管基础设施方面的大量前期投资，同时也能获得最尖端科技和专业知识。这一趋势正在扩大品质控制服务供应商的目标市场，促进合作与策略伙伴关係，并支持mRNA品质监测产业产品和服务领域的成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章 mRNA品质监测市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • mRNA品质监测市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章 mRNA品质监测市场：产品与服务估算及趋势分析

  • 细分仪表板
  • 全球mRNA品质监测市场：产品与服务差异分析
  • 全球mRNA品质监测市场规模及趋势分析（依产品/服务划分，2021-2033年）
  • 试剂盒/检测和试剂
  • 设备和软体
  • 品质控制测试服务

第五章 mRNA品质监测市场：技术预测与趋势分析

  • 细分仪表板
  • 全球mRNA品质监测市场：技术差异分析
  • 全球mRNA品质监测市场规模及趋势分析（依技术划分，2021-2033年）
  • LC-MS
  • 电泳
  • ELISA
  • PCR技术
  • 其他技术

第六章 mRNA品质监测市场：终端用户需求预测及趋势分析

  • 细分仪表板
  • 全球mRNA品质监测市场：最终用途变异性分析
  • 全球mRNA品质监测市场规模及趋势分析（依最终用途划分，2021-2033年）
  • 生物製药和生物技术公司
  • CDMO、CRO、分析实验室
  • 学术研究机构和中心

第七章 mRNA品质监测市场：区域估算与趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场概览
  • 市场规模、预测趋势分析（2021-2033）：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 企业市场分析，2024年
  • 公司简介
    • Revvity, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Waters Corporation
    • Creative Diagnostics
    • GenScript
    • TriLink BioTechnologies（Maravai LifeSciences）
    • Creative Biolabs
    • Vazyme International LLC
Product Code: GVR-4-68040-764-5

mRNA Quality Monitoring Market Summary

The global mRNA quality monitoring market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 2.33 billion by 2033, growing at a CAGR of 6.93% from 2025 to 2033. Growing adoption of mRNA-based therapeutics and vaccines drives demand for robust quality monitoring to ensure product safety, efficacy, and regulatory compliance. Furthermore, advancements in analytical technologies (LC-MS, electrophoresis, qPCR) and rising outsourcing to CDMOs/CROs further accelerate market growth.

Surge in mRNA-Based Therapeutics & Vaccines

Biopharma firms have greatly expanded their pipelines beyond infectious diseases as a result of the success of COVID-19 vaccines, which has brought mRNA into the public eye. By significantly expanding the scale and complexity of production, Moderna, BioNTech, and CureVac are developing mRNA therapies for protein replacement, rare diseases, and oncology. In order to comply with GMP and regulatory requirements, more batches must go through thorough quality monitoring, which covers integrity, purity, capping efficiency, and residual contaminants.

Globally, large capacity investments support this trend. To increase vaccine production, BioNTech is setting up modular mRNA manufacturing units (BioNTainers) in Rwanda and has constructed a new plasmid DNA manufacturing facility in Marburg, Germany. In a similar way, Moderna established a commercial mRNA plant in Melbourne, Australia, that can generate up to 100 million doses per year. The mRNA quality monitoring industry is driven by the need for sophisticated analytical tools like LC-MS, electrophoresis, and PCR because every facility needs to conduct thorough QC testing at several stages, from raw material verification to the release of the finished product.

Technology Innovation & Outsourcing Trends

Rapid advancements in digital and analytical technologies are revolutionizing the monitoring of mRNA quality. The detailed structural characterization of mRNA is now possible thanks to the increased sensitivity and quicker run times of next-generation LC-MS systems. In addition, capillary electrophoresis based on microfluidics enables high-throughput integrity analysis using small sample volumes. For accurate quantification and sequence verification, next-generation sequencing (NGS) and digital PCR (dPCR) are also combined. In order to scale mRNA manufacturing from clinical to commercial production, these developments are increasing the automation, standardization, and reproducibility of QC workflows.

In parallel, many small- and mid-sized biotech firms are increasingly outsourcing QC activities to CDMOs, CROs, and specialized analytical labs. Outsourcing allows these companies to avoid high upfront investments in instruments and regulatory compliance infrastructure, while still accessing state-of-the-art technology and expertise. This trend is expanding the addressable market for QC service providers, driving collaborations and strategic partnerships, and fueling growth across both product and service segments of the mRNA quality monitoring industry.

Global mRNA Quality Monitoring Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global mRNA quality monitoring market on the basis of product & service, technology, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits/Assays & Reagents
  • Instruments & Software
  • QC Testing Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • LC-MS
  • Electrophoresis
  • ELISA
  • PCR Techniques
  • Other Technologies
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical & Biotechnology Companies
  • CDMOs, CROs & Analytical Labs
  • Academic & Research Institutes/Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Technology Segment
    • 1.2.3. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. mRNA Quality Monitoring Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Demand for mRNA-Based Therapeutics and Vaccines
      • 3.2.1.2. Regulatory Focus on Product Safety and Consistency
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Quality Monitoring Systems
      • 3.2.2.2. Technical Complexity and Skilled Workforce Requirement
  • 3.3. MRNA quality monitoring market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. mRNA Quality Monitoring Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global mRNA Quality Monitoring Market Product & Service Movement Analysis
  • 4.3. Global mRNA Quality Monitoring Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Kits/Assays & Reagents
    • 4.4.1. Kits/Assays & reagents market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Instruments & Software
    • 4.5.1. Instruments & software market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. QC Testing Services
    • 4.6.1. QC testing services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. mRNA Quality Monitoring Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global mRNA Quality Monitoring Market Technology Movement Analysis
  • 5.3. Global mRNA Quality Monitoring Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. LC-MS
    • 5.4.1. LC-MS market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Electrophoresis
    • 5.5.1. Electrophoresis market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. ELISA
    • 5.6.1. ELISA market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. PCR Techniques
    • 5.7.1. PCR techniques market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Other Technologies
    • 5.8.1. Other technologies market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. mRNA Quality Monitoring Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global mRNA Quality Monitoring Market End Use Movement Analysis
  • 6.3. Global mRNA Quality Monitoring Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Biotechnology Companies
    • 6.4.1. Biopharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. CDMOs, CROs & Analytical Labs
    • 6.5.1. CDMOs, CROs & analytical labs market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Academic & Research Institutes/Centers
    • 6.6.1. Academic & research institutes/centers market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. mRNA Quality Monitoring Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Competitive scenario
      • 7.4.1.3. Regulatory Framework
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory Framework
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory Framework
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory Framework
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory Framework
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Revvity, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product/Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Agilent Technologies, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product/Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Bio-Rad Laboratories, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product/Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product/Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Waters Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product/Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Creative Diagnostics
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product/Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. GenScript
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product/Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. TriLink BioTechnologies (Maravai LifeSciences)
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product/Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Creative Biolabs
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product/Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Vazyme International LLC
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product/Service benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global mRNA quality monitoring market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 4 Global mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 8 North America mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 11 U.S. mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 14 Canada mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 15 Canada mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 17 Mexico mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 21 Europe mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Europe mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 24 UK mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 27 Germany mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Germany mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 30 France mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 31 France mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 33 Italy mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Italy mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 36 Spain mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Spain mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 39 Denmark mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 42 Sweden mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 45 Norway mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Norway mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 52 China mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 53 China mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 55 Japan mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 56 Japan mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 58 India mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 59 India mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 61 South Korea mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 62 South Korea mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 64 Australia mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Australia mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 67 Thailand mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 68 Thailand mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 71 Latin America mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 72 Latin America mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 74 Brazil mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 75 Brazil mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 77 Argentina mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 78 Argentina mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 81 MEA mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 82 MEA mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 84 South Africa mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 85 South Africa mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 90 UAE mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 91 UAE mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 93 Kuwait mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 94 Kuwait mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 mRNA Quality Monitoring Market: Market outlook
  • Fig. 5 mRNA Quality Monitoring Market: Segment outlook
  • Fig. 6 mRNA Quality Monitoring Market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 mRNA quality monitoring market driver impact
  • Fig. 9 mRNA quality monitoring market restraint impact
  • Fig. 10 mRNA Quality Monitoring Market: Product & service outlook and key takeaways
  • Fig. 11 mRNA Quality Monitoring Market: Product & service movement analysis
  • Fig. 12 Kits/Assays & reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 13 Instruments & software market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 14 QC testing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 mRNA Quality Monitoring Market: Technology outlook and key takeaways
  • Fig. 16 mRNA Quality Monitoring Market: Technology movement analysis
  • Fig. 17 LC-MS market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Electrophoresis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 ELISA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 PCR Techniques market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Other technologies market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 mRNA Quality Monitoring Market: End use outlook and key takeaways
  • Fig. 23 mRNA Quality Monitoring Market: End use movement analysis
  • Fig. 24 Biopharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 CDMOs, CROs & analytical labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Academic & research institutes/centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Global mRNA quality monitoring market: Regional outlook and key takeaways
  • Fig. 28 Global mRNA quality monitoring market: Regional movement analysis
  • Fig. 29 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)